男性避孕：现状与未来前景。 - Suppr

Suppr

超能文献

Male contraception: current status and future prospects.

作者信息

Wu F C

机构信息

MRC Reproductive Biology Unit, Edinburgh, UK.

出版信息

Clin Endocrinol (Oxf). 1988 Oct;29(4):443-65. doi: 10.1111/j.1365-2265.1988.tb02894.x.

DOI:10.1111/j.1365-2265.1988.tb02894.x

PMID:3075164

Abstract

摘要

相似文献

Male contraception: current status and future prospects.

Clin Endocrinol (Oxf). 1988 Oct;29(4):443-65. doi: 10.1111/j.1365-2265.1988.tb02894.x.

The influence of pharmaceutical compounds on male fertility.

Andrologia. 1976;8(3):203-35. doi: 10.1111/j.1439-0272.1976.tb02137.x.

Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.

J Clin Endocrinol Metab. 1996 Nov;81(11):4113-21. doi: 10.1210/jcem.81.11.8923869.

Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.

Int J Androl. 1988 Jun;11(3):187-99. doi: 10.1111/j.1365-2605.1988.tb00994.x.

[Male contraception in 1987].

Rev Prat. 1987 Sep 21;37(38):2302-11.

Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.

J Clin Endocrinol Metab. 1992 Jan;74(1):84-90. doi: 10.1210/jcem.74.1.1727833.

Target sites for suppressing fertility in the male.

Adv Sex Horm Res. 1976;2:263-87.

Possible physiological bases for contraceptive techniques in the male.

Hum Reprod. 1994 Jun;9(6):1081-7. doi: 10.1093/oxfordjournals.humrep.a138637.

Looking for the "male pill".

Netw Res Triangle Park N C. 1992 Aug;13(1):20-3.

Developments in the control of testicular function.

Baillieres Clin Endocrinol Metab. 1992 Apr;6(2):451-83. doi: 10.1016/s0950-351x(05)80158-2.

引用本文的文献

Prospects for pharmacological male contraception.

Drugs. 1994 Dec;48(6):851-63. doi: 10.2165/00003495-199448060-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Male contraception: current status and future prospects.

Clin Endocrinol (Oxf). 1988 Oct;29(4):443-65. doi: 10.1111/j.1365-2265.1988.tb02894.x.

The influence of pharmaceutical compounds on male fertility.

Andrologia. 1976;8(3):203-35. doi: 10.1111/j.1439-0272.1976.tb02137.x.

Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.

J Clin Endocrinol Metab. 1996 Nov;81(11):4113-21. doi: 10.1210/jcem.81.11.8923869.

Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.

Int J Androl. 1988 Jun;11(3):187-99. doi: 10.1111/j.1365-2605.1988.tb00994.x.

[Male contraception in 1987].

Rev Prat. 1987 Sep 21;37(38):2302-11.

Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.

J Clin Endocrinol Metab. 1992 Jan;74(1):84-90. doi: 10.1210/jcem.74.1.1727833.

Target sites for suppressing fertility in the male.

Adv Sex Horm Res. 1976;2:263-87.

Possible physiological bases for contraceptive techniques in the male.

Hum Reprod. 1994 Jun;9(6):1081-7. doi: 10.1093/oxfordjournals.humrep.a138637.

Looking for the "male pill".

Netw Res Triangle Park N C. 1992 Aug;13(1):20-3.

Developments in the control of testicular function.

Baillieres Clin Endocrinol Metab. 1992 Apr;6(2):451-83. doi: 10.1016/s0950-351x(05)80158-2.

引用本文的文献

Prospects for pharmacological male contraception.

Drugs. 1994 Dec;48(6):851-63. doi: 10.2165/00003495-199448060-00002.